VKTXNasdaq United States
Market cap
$3.997 B
$34.26 +2.88%
Close of 7 Aug 2026
Revenue
$0.00
#3658 by revenue
Earnings
-$359.6M
Loss-making
Shares outstanding
116,652,937
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Viking Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.